Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm
Interview with Barry H. Greenberg, author of Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial, and Marvin A. Konstam, MD, author of Antithrombotic Therapy in Heart Failure—The Clot Thickens
